Lexaria BioscienceLEXX
13F holders, Q3 2025 (September 30)25holders +4
7new positions
3sold out
1famous investor
$0.95avg. 13F price*
At the end of Q3 2025, 25 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, up 4 from Q2 2025. 7 opened new positions and 3 sold out. The largest holders were Invenomic Capital Management LP ($455K), Murchinson Ltd. ($400K) and Vanguard Group Inc. ($247K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $459K |
| Exits | 3 | $1.0M |
All 13F filers, Q2 2025 → Q3 2025: 619,167 shares bought and 1,199,300 shares sold, net −580,133 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Invenomic Capital Management LP | 0.02% | Reduce -4.8% | 477,201 | $455K |
| Murchinson Ltd. | 0.08% | New | 419,590 | $400K |
| Vanguard Group Inc. | 0.00% | Add +93.8% | 258,816 | $247K |
| Geode Capital Management, LLC | 0.00% | No change | 174,779 | $167K |
| Toronto Dominion Bank | 0.00% | Add +5.2% | 140,013 | $133K |
| State Street Corp. | 0.00% | No change | 39,301 | $37K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +16.3% | 35,776 | $30K |
| Byrne Asset Management LLC | 0.02% | Reduce -8.4% | 31,320 | $30K |
| Virtu Financial LLC | 0.00% | New | 29,360 | $28K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $26K |
| Krilogy Financial LLC | 0.00% | New | 19,653 | $21K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $18K |
| Bank of Montreal | 0.00% | No change | 14,033 | $13K |
| Renaissance Technologies | 0.00% | New | 10,100 | $10K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $7K |
| UBS Group AG | 0.00% | Add +16.7% | 7,090 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +84.4% | 3,622 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 2,190 | $2K |
| Citigroup Inc. | 0.00% | New | 429 | $409 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 382 | $362 |
| Rockefeller Capital Management L.P. | 0.00% | New | 200 | $191 |
| Bank of America Corp. | 0.00% | Add +3.0% | 173 | $164 |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $158 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $12 |
| PNC Financial Services Group, Inc. | 0.00% | New | 6 | $6 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.